—

Crinetics Pharmaceuticals Inc (CRNX) — the peer cohort

As of 2026-10-15 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Crinetics Pharmaceuticals Inc ranks 7 of 7 in its cohort on the Closelooknet composite (49/100) — the cohort is led by Halozyme Therapeutics Inc at 75/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
CRNX Crinetics Pharmaceuticals Inc 49 99 21 5 ok 0.1%
HALO Halozyme Therapeutics Inc 75 98 94 47 ok 0.7%
ARGX.BR Argen-X 64 64 75 28 info 18%
ONC BeiGene, Ltd. 64 84 63 30 ok 2.9%
ARGX argenx NV ADR 62 56 74 28 info 21.1%
UCB.BR UCB SA 61 20 70 57 warn 28.5%
KRYS Krystal Biotech Inc 60 64 85 16 info 13.7%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-15

Quick answers

Who are Crinetics Pharmaceuticals Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), Argen-X (ARGX.BR), BeiGene, Ltd. (ONC), argenx NV ADR (ARGX), UCB SA (UCB.BR), Krystal Biotech Inc (KRYS).

How does CRNX score against its peers?

Crinetics Pharmaceuticals Inc's composite reads 49/100, ranking 7 of 7 in its cohort as of 2026-10-15; the cohort's highest composite is Halozyme Therapeutics Inc at 75/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.